Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer.

Esper RC, Estrada IE, de la Torre León T, Gutiérrez AO, López JA.

J Intensive Care. 2014 Aug 27;2(1):47. doi: 10.1186/s40560-014-0047-2. eCollection 2014.

2.

Diffuse alveolar hemorrhage: a rare life-threatening condition in systemic lupus erythematosus.

Virdi RP, Bashir A, Shahzad G, Iqbal J, Mejia JO.

Case Rep Pulmonol. 2012;2012:836017. doi: 10.1155/2012/836017. Epub 2012 May 27.

3.

Bench-to-bedside review: pulmonary-renal syndromes--an update for the intensivist.

Papiris SA, Manali ED, Kalomenidis I, Kapotsis GE, Karakatsani A, Roussos C.

Crit Care. 2007;11(3):213. Review.

4.

The emergency room in systemic rheumatic diseases.

Slobodin G, Hussein A, Rozenbaum M, Rosner I.

Emerg Med J. 2006 Sep;23(9):667-71. Review.

5.

Pulmonary alveolar hemorrhage in a pregnancy complicated by systemic lupus erythematosus.

Gaither K, Halstead K, Mason TC.

J Natl Med Assoc. 2005 Jun;97(6):831-3.

6.

Protein kinase C (PKC) dependent induction of tissue factor (TF) by mesangial cells in response to inflammatory mediators and release during apoptosis.

Lang D, Terstesse M, Dohle F, Bangen P, Banas B, Pauels HG, Heidenreich S.

Br J Pharmacol. 2002 Dec;137(7):1116-24.

Supplemental Content

Support Center